Is the Blackmores (ASX:BKL) share price in the buy zone?

The Blackmores Limited (ASX:BKL) share price came under pressure following its update. Is now a good time to buy its shares?

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Blackmores Limited (ASX: BKL) share price was out of form on Thursday.

The health supplements company's shares dropped 4.5% to $80.60.

blackmores share price

Image source: Getty Images

Why did the Blackmores share price tumble lower?

Investors were selling the company's shares yesterday following the release of its shareholder update.

While no sales or profit data was provided, the update did reveal that trading conditions remain tough.

This is due to pressures in the daigou channel because of COVID-19, a milder cold and flu season, and a shift in shopping trends.

Is this a buying opportunity?

Yesterday's decline means the Blackmores share price is now trading 9% lower than its 52-week high.

However, one leading broker believes investors should be sitting tight and waiting for a better entry point.

According to a note out of Goldman Sachs, its analysts have retained their neutral rating and cut the price target on its shares to $74.80.

Based on the current Blackmores share price, this implies potential downside of over 7%.

What did Goldman say?

Goldman was happy with the progress of its expansion into India and its investment in digital and supply chain projects. It expects the latter to improve efficiency and drive gross margin improvements.

However, it has concerns over its short term performance.

Goldman said: "Short-term outlook remains uncertain due to ongoing discounting pressure in the market and uncertainty in travel recovery. Capital expenditure is expected to accelerate from 2H22. Dividend payout ratio target has been reduced to 30-60%. Overall, while longer-term growth and expansion opportunities look positive, we think short-term uncertainties remain material. We revise our FY22E and FY23E EBIT forecasts by -8.6% and -5.1% respectively/ Our revised 12m Target Price on BKL is A$74.80. We maintain our Neutral rating on BKL."

Goldman isn't the only broker that is unsure about Blackmores at present. On Thursday, Citi put a sell rating and lowly $59.20 price target on Blackmores' shares. It has concerns over demand in the lucrative China market.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Blackmores Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Westpac and CBA shares

A leading expert forecasts growing headwinds for Westpac and CBA shares.

Read more »

Man looking at digital holograms of graphs, charts, and data.
Broker Notes

Expert names 2 ASX tech shares to buy today

A top analyst says these two ASX tech stocks are well-positioned to outperform.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

4 ASX All Ords shares with 40% to 90% upside post-results: experts

These shares have major upside potential, according to the experts.

Read more »

Woman looking at a laptop and thinking.
Broker Notes

4 ASX shares scoring upgrades in the final week of earnings season

Brokers have increased their ratings on Sigma Healthcare, Adairs, Netwealth, and other shares.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Buy, hold, sell: Netwealth, Sigma Healthcare, and Wesfarmers shares

The team at Morgans has given its verdict on these shares.

Read more »

Smiling kid flexing his muscles.
Broker Notes

3 ASX 200 shares to buy post-results: broker

Morgans has reviewed these companies' FY26 reports and given them a buy rating.

Read more »

Small kid giving a thumbs up.
Broker Notes

9 ASX 200 shares with strengthened buy ratings this week

Brokers are positive on Paladin Energy, Coles, WiseTech, Centuria Capital, and other shares.

Read more »

A couple in a supermarket laugh as they discuss which fruits and vegetables to buy
Broker Notes

Buy, hold, sell: Ramsay Health Care, PLS Group, Woolworths shares

Morgans has updated its ratings and 12-month price targets on these 3 ASX 200 shares.

Read more »